Filing Details

Accession Number:
0001437749-18-011850
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-14 17:20:30
Reporting Period:
2018-05-16
Accepted Time:
2018-06-14 17:20:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029125 Sun Biopharma Inc. SNBP Pharmaceutical Preparations (2834) 870543922
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1133026 B David Kaysen 712 Vista Blvd #305
Waconia MN 55387
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-16 1,000 $0.00 51,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to buy) Acquisiton 2018-05-16 1,000 $0.00 1,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2018-05-16 2021-05-16 No 4 P Direct
Footnotes
  1. Reflects purchase of 1,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.